Lymphoedema: an underestimated health problem
Identifieur interne : 000655 ( PascalFrancis/Corpus ); précédent : 000654; suivant : 000656Lymphoedema: an underestimated health problem
Auteurs : C. J. Moffatt ; P. J. Franks ; D. C. Doherty ; A. F. Williams ; C. Badger ; E. Jeffs ; N. Bosanquet ; P. S. MortimerSource :
- QJM : (Oxford. 1994. Print) [ 1460-2725 ] ; 2003.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Background: Lymphoedema/chronic oedema is an important cause of morbidity in the population, but little is known of its epidemiology and impact on patients or health services. Aim: To determine the magnitude of the problem of chronic oedema in the community, and the likely impact of oedema on use of health resources, employment and patient's quality of life. Design: Questionnaire-based survey. Methods: Health professionals from dedicated lymphoedema services, specific out-patient clinics, hospital wards and community services (GP clinics and district nurses) were contacted to provide information on patients from within South West London Community Trust. A subset of the identified patients was interviewed. Results: Within the catchment area, 823 patients had chronic oedema (crude prevalence 1.33/1000). Prevalence increased with age (5.4/1000 in those aged > 65 years), and was higher in women (2.15 vs. 0.47/1000). Only 529 (64%) were receiving treatment, despite two specialist lymphoedema clinics within the catchment area. Of 228 patients interviewed, 78% had oedema lasting > 1 year. Over the previous year, 64/218 (29%) had had an acute infection in the affected area, 17/64 (27%) being admitted for intravenous antibiotics. Mean length of stay for this condition was 12 days, estimated mean cost £2300. Oedema caused time off work in >80%, and affected employment status in 9%. Quality of life was below normal, with 50% experiencing pain or discomfort from their oedema. Discussion: Chronic oedema is a common problem in the community with at least 100000 patients suffering in the UK alone, a problem poorly recognized by health professionals. Lymphoedema arising for reasons other than cancer treatment is much more prevalent than generally perceived, yet resources for treatment are mainly cancer-based, leading to inequalities of care.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 04-0089879 INIST |
---|---|
ET : | Lymphoedema: an underestimated health problem |
AU : | MOFFATT (C. J.); FRANKS (P. J.); DOHERTY (D. C.); WILLIAMS (A. F.); BADGER (C.); JEFFS (E.); BOSANQUET (N.); MORTIMER (P. S.) |
AF : | Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University/London/Royaume-Uni (1 aut., 2 aut., 3 aut., 4 aut.); St George's Hospital Medical School/London/Royaume-Uni (5 aut., 8 aut.); The Haven Trust/London/Royaume-Uni (6 aut.); Department of Bio-engineering, Imperial College/London/Royaume-Uni (7 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | QJM : (Oxford. 1994. Print); ISSN 1460-2725; Royaume-Uni; Da. 2003; Vol. 96; No. 10; Pp. 731-738; Bibl. 21 ref. |
LA : | Anglais |
EA : | Background: Lymphoedema/chronic oedema is an important cause of morbidity in the population, but little is known of its epidemiology and impact on patients or health services. Aim: To determine the magnitude of the problem of chronic oedema in the community, and the likely impact of oedema on use of health resources, employment and patient's quality of life. Design: Questionnaire-based survey. Methods: Health professionals from dedicated lymphoedema services, specific out-patient clinics, hospital wards and community services (GP clinics and district nurses) were contacted to provide information on patients from within South West London Community Trust. A subset of the identified patients was interviewed. Results: Within the catchment area, 823 patients had chronic oedema (crude prevalence 1.33/1000). Prevalence increased with age (5.4/1000 in those aged > 65 years), and was higher in women (2.15 vs. 0.47/1000). Only 529 (64%) were receiving treatment, despite two specialist lymphoedema clinics within the catchment area. Of 228 patients interviewed, 78% had oedema lasting > 1 year. Over the previous year, 64/218 (29%) had had an acute infection in the affected area, 17/64 (27%) being admitted for intravenous antibiotics. Mean length of stay for this condition was 12 days, estimated mean cost £2300. Oedema caused time off work in >80%, and affected employment status in 9%. Quality of life was below normal, with 50% experiencing pain or discomfort from their oedema. Discussion: Chronic oedema is a common problem in the community with at least 100000 patients suffering in the UK alone, a problem poorly recognized by health professionals. Lymphoedema arising for reasons other than cancer treatment is much more prevalent than generally perceived, yet resources for treatment are mainly cancer-based, leading to inequalities of care. |
CC : | 002B12B06 |
FD : | Lymphoedème; Homme; Royaume Uni; Chronique; Evaluation; Soin; Qualité vie; Emploi; Sexe; Age; Santé publique; Epidémiologie; Traitement; Enquête; Questionnaire; Service santé; Personnel sanitaire; Utilisateur; Morbidité |
FG : | Europe; Appareil circulatoire pathologie; Lymphatique pathologie |
ED : | Lymphedema; Human; United Kingdom; Chronic; Evaluation; Care; Quality of life; Employment; Sex; Age; Public health; Epidemiology; Treatment; Survey; Questionnaire; Health service; Health staff; User; Morbidity |
EG : | Europe; Cardiovascular disease; Lymphatic vessel disease |
SD : | Linfedema; Hombre; Reino Unido; Crónico; Evaluación; Cuidado; Calidad vida; Empleo; Sexo; Edad; Salud pública; Epidemiología; Tratamiento; Encuesta; Cuestionario; Servicio sanidad; Personal sanitario; Usuario; Morbilidad |
LO : | INIST-5050.354000114843840040 |
ID : | 04-0089879 |
Links to Exploration step
Pascal:04-0089879Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Lymphoedema: an underestimated health problem</title>
<author><name sortKey="Moffatt, C J" sort="Moffatt, C J" uniqKey="Moffatt C" first="C. J." last="Moffatt">C. J. Moffatt</name>
<affiliation><inist:fA14 i1="01"><s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Franks, P J" sort="Franks, P J" uniqKey="Franks P" first="P. J." last="Franks">P. J. Franks</name>
<affiliation><inist:fA14 i1="01"><s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Doherty, D C" sort="Doherty, D C" uniqKey="Doherty D" first="D. C." last="Doherty">D. C. Doherty</name>
<affiliation><inist:fA14 i1="01"><s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Williams, A F" sort="Williams, A F" uniqKey="Williams A" first="A. F." last="Williams">A. F. Williams</name>
<affiliation><inist:fA14 i1="01"><s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Badger, C" sort="Badger, C" uniqKey="Badger C" first="C." last="Badger">C. Badger</name>
<affiliation><inist:fA14 i1="02"><s1>St George's Hospital Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Jeffs, E" sort="Jeffs, E" uniqKey="Jeffs E" first="E." last="Jeffs">E. Jeffs</name>
<affiliation><inist:fA14 i1="03"><s1>The Haven Trust</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bosanquet, N" sort="Bosanquet, N" uniqKey="Bosanquet N" first="N." last="Bosanquet">N. Bosanquet</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Bio-engineering, Imperial College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mortimer, P S" sort="Mortimer, P S" uniqKey="Mortimer P" first="P. S." last="Mortimer">P. S. Mortimer</name>
<affiliation><inist:fA14 i1="02"><s1>St George's Hospital Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0089879</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 04-0089879 INIST</idno>
<idno type="RBID">Pascal:04-0089879</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000655</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Lymphoedema: an underestimated health problem</title>
<author><name sortKey="Moffatt, C J" sort="Moffatt, C J" uniqKey="Moffatt C" first="C. J." last="Moffatt">C. J. Moffatt</name>
<affiliation><inist:fA14 i1="01"><s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Franks, P J" sort="Franks, P J" uniqKey="Franks P" first="P. J." last="Franks">P. J. Franks</name>
<affiliation><inist:fA14 i1="01"><s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Doherty, D C" sort="Doherty, D C" uniqKey="Doherty D" first="D. C." last="Doherty">D. C. Doherty</name>
<affiliation><inist:fA14 i1="01"><s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Williams, A F" sort="Williams, A F" uniqKey="Williams A" first="A. F." last="Williams">A. F. Williams</name>
<affiliation><inist:fA14 i1="01"><s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Badger, C" sort="Badger, C" uniqKey="Badger C" first="C." last="Badger">C. Badger</name>
<affiliation><inist:fA14 i1="02"><s1>St George's Hospital Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Jeffs, E" sort="Jeffs, E" uniqKey="Jeffs E" first="E." last="Jeffs">E. Jeffs</name>
<affiliation><inist:fA14 i1="03"><s1>The Haven Trust</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bosanquet, N" sort="Bosanquet, N" uniqKey="Bosanquet N" first="N." last="Bosanquet">N. Bosanquet</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Bio-engineering, Imperial College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mortimer, P S" sort="Mortimer, P S" uniqKey="Mortimer P" first="P. S." last="Mortimer">P. S. Mortimer</name>
<affiliation><inist:fA14 i1="02"><s1>St George's Hospital Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">QJM : (Oxford. 1994. Print)</title>
<title level="j" type="abbreviated">QJM : (Oxf., 1994, Print)</title>
<idno type="ISSN">1460-2725</idno>
<imprint><date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">QJM : (Oxford. 1994. Print)</title>
<title level="j" type="abbreviated">QJM : (Oxf., 1994, Print)</title>
<idno type="ISSN">1460-2725</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age</term>
<term>Care</term>
<term>Chronic</term>
<term>Employment</term>
<term>Epidemiology</term>
<term>Evaluation</term>
<term>Health service</term>
<term>Health staff</term>
<term>Human</term>
<term>Lymphedema</term>
<term>Morbidity</term>
<term>Public health</term>
<term>Quality of life</term>
<term>Questionnaire</term>
<term>Sex</term>
<term>Survey</term>
<term>Treatment</term>
<term>United Kingdom</term>
<term>User</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Lymphoedème</term>
<term>Homme</term>
<term>Royaume Uni</term>
<term>Chronique</term>
<term>Evaluation</term>
<term>Soin</term>
<term>Qualité vie</term>
<term>Emploi</term>
<term>Sexe</term>
<term>Age</term>
<term>Santé publique</term>
<term>Epidémiologie</term>
<term>Traitement</term>
<term>Enquête</term>
<term>Questionnaire</term>
<term>Service santé</term>
<term>Personnel sanitaire</term>
<term>Utilisateur</term>
<term>Morbidité</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background: Lymphoedema/chronic oedema is an important cause of morbidity in the population, but little is known of its epidemiology and impact on patients or health services. Aim: To determine the magnitude of the problem of chronic oedema in the community, and the likely impact of oedema on use of health resources, employment and patient's quality of life. Design: Questionnaire-based survey. Methods: Health professionals from dedicated lymphoedema services, specific out-patient clinics, hospital wards and community services (GP clinics and district nurses) were contacted to provide information on patients from within South West London Community Trust. A subset of the identified patients was interviewed. Results: Within the catchment area, 823 patients had chronic oedema (crude prevalence 1.33/1000). Prevalence increased with age (5.4/1000 in those aged > 65 years), and was higher in women (2.15 vs. 0.47/1000). Only 529 (64%) were receiving treatment, despite two specialist lymphoedema clinics within the catchment area. Of 228 patients interviewed, 78% had oedema lasting > 1 year. Over the previous year, 64/218 (29%) had had an acute infection in the affected area, 17/64 (27%) being admitted for intravenous antibiotics. Mean length of stay for this condition was 12 days, estimated mean cost £2300. Oedema caused time off work in >80%, and affected employment status in 9%. Quality of life was below normal, with 50% experiencing pain or discomfort from their oedema. Discussion: Chronic oedema is a common problem in the community with at least 100000 patients suffering in the UK alone, a problem poorly recognized by health professionals. Lymphoedema arising for reasons other than cancer treatment is much more prevalent than generally perceived, yet resources for treatment are mainly cancer-based, leading to inequalities of care.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>1460-2725</s0>
</fA01>
<fA03 i2="1"><s0>QJM : (Oxf., 1994, Print)</s0>
</fA03>
<fA05><s2>96</s2>
</fA05>
<fA06><s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Lymphoedema: an underestimated health problem</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MOFFATT (C. J.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>FRANKS (P. J.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>DOHERTY (D. C.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>WILLIAMS (A. F.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>BADGER (C.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>JEFFS (E.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>BOSANQUET (N.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>MORTIMER (P. S.)</s1>
</fA11>
<fA14 i1="01"><s1>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>St George's Hospital Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>The Haven Trust</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Bio-engineering, Imperial College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>731-738</s1>
</fA20>
<fA21><s1>2003</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>5050</s2>
<s5>354000114843840040</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2004 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>21 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>04-0089879</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>QJM : (Oxford. 1994. Print)</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Background: Lymphoedema/chronic oedema is an important cause of morbidity in the population, but little is known of its epidemiology and impact on patients or health services. Aim: To determine the magnitude of the problem of chronic oedema in the community, and the likely impact of oedema on use of health resources, employment and patient's quality of life. Design: Questionnaire-based survey. Methods: Health professionals from dedicated lymphoedema services, specific out-patient clinics, hospital wards and community services (GP clinics and district nurses) were contacted to provide information on patients from within South West London Community Trust. A subset of the identified patients was interviewed. Results: Within the catchment area, 823 patients had chronic oedema (crude prevalence 1.33/1000). Prevalence increased with age (5.4/1000 in those aged > 65 years), and was higher in women (2.15 vs. 0.47/1000). Only 529 (64%) were receiving treatment, despite two specialist lymphoedema clinics within the catchment area. Of 228 patients interviewed, 78% had oedema lasting > 1 year. Over the previous year, 64/218 (29%) had had an acute infection in the affected area, 17/64 (27%) being admitted for intravenous antibiotics. Mean length of stay for this condition was 12 days, estimated mean cost £2300. Oedema caused time off work in >80%, and affected employment status in 9%. Quality of life was below normal, with 50% experiencing pain or discomfort from their oedema. Discussion: Chronic oedema is a common problem in the community with at least 100000 patients suffering in the UK alone, a problem poorly recognized by health professionals. Lymphoedema arising for reasons other than cancer treatment is much more prevalent than generally perceived, yet resources for treatment are mainly cancer-based, leading to inequalities of care.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B12B06</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Homme</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Human</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Hombre</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Royaume Uni</s0>
<s2>NG</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>United Kingdom</s0>
<s2>NG</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Reino Unido</s0>
<s2>NG</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Chronique</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Chronic</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Crónico</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Evaluation</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Evaluation</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Evaluación</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Soin</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Care</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Cuidado</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Qualité vie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Quality of life</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Calidad vida</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Emploi</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Employment</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Empleo</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Sexe</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Sex</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Sexo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Age</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Age</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Edad</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Santé publique</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Public health</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Salud pública</s0>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>12</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Traitement</s0>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Treatment</s0>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>13</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Enquête</s0>
<s5>18</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Survey</s0>
<s5>18</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Encuesta</s0>
<s5>18</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Questionnaire</s0>
<s5>19</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Questionnaire</s0>
<s5>19</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Cuestionario</s0>
<s5>19</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Service santé</s0>
<s5>20</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Health service</s0>
<s5>20</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Servicio sanidad</s0>
<s5>20</s5>
</fC03>
<fC03 i1="17" i2="X" l="FRE"><s0>Personnel sanitaire</s0>
<s5>21</s5>
</fC03>
<fC03 i1="17" i2="X" l="ENG"><s0>Health staff</s0>
<s5>21</s5>
</fC03>
<fC03 i1="17" i2="X" l="SPA"><s0>Personal sanitario</s0>
<s5>21</s5>
</fC03>
<fC03 i1="18" i2="X" l="FRE"><s0>Utilisateur</s0>
<s5>22</s5>
</fC03>
<fC03 i1="18" i2="X" l="ENG"><s0>User</s0>
<s5>22</s5>
</fC03>
<fC03 i1="18" i2="X" l="SPA"><s0>Usuario</s0>
<s5>22</s5>
</fC03>
<fC03 i1="19" i2="X" l="FRE"><s0>Morbidité</s0>
<s5>23</s5>
</fC03>
<fC03 i1="19" i2="X" l="ENG"><s0>Morbidity</s0>
<s5>23</s5>
</fC03>
<fC03 i1="19" i2="X" l="SPA"><s0>Morbilidad</s0>
<s5>23</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Europe</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Europe</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Europa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Lymphatique pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>38</s5>
</fC07>
<fN21><s1>061</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 04-0089879 INIST</NO>
<ET>Lymphoedema: an underestimated health problem</ET>
<AU>MOFFATT (C. J.); FRANKS (P. J.); DOHERTY (D. C.); WILLIAMS (A. F.); BADGER (C.); JEFFS (E.); BOSANQUET (N.); MORTIMER (P. S.)</AU>
<AF>Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University/London/Royaume-Uni (1 aut., 2 aut., 3 aut., 4 aut.); St George's Hospital Medical School/London/Royaume-Uni (5 aut., 8 aut.); The Haven Trust/London/Royaume-Uni (6 aut.); Department of Bio-engineering, Imperial College/London/Royaume-Uni (7 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>QJM : (Oxford. 1994. Print); ISSN 1460-2725; Royaume-Uni; Da. 2003; Vol. 96; No. 10; Pp. 731-738; Bibl. 21 ref.</SO>
<LA>Anglais</LA>
<EA>Background: Lymphoedema/chronic oedema is an important cause of morbidity in the population, but little is known of its epidemiology and impact on patients or health services. Aim: To determine the magnitude of the problem of chronic oedema in the community, and the likely impact of oedema on use of health resources, employment and patient's quality of life. Design: Questionnaire-based survey. Methods: Health professionals from dedicated lymphoedema services, specific out-patient clinics, hospital wards and community services (GP clinics and district nurses) were contacted to provide information on patients from within South West London Community Trust. A subset of the identified patients was interviewed. Results: Within the catchment area, 823 patients had chronic oedema (crude prevalence 1.33/1000). Prevalence increased with age (5.4/1000 in those aged > 65 years), and was higher in women (2.15 vs. 0.47/1000). Only 529 (64%) were receiving treatment, despite two specialist lymphoedema clinics within the catchment area. Of 228 patients interviewed, 78% had oedema lasting > 1 year. Over the previous year, 64/218 (29%) had had an acute infection in the affected area, 17/64 (27%) being admitted for intravenous antibiotics. Mean length of stay for this condition was 12 days, estimated mean cost £2300. Oedema caused time off work in >80%, and affected employment status in 9%. Quality of life was below normal, with 50% experiencing pain or discomfort from their oedema. Discussion: Chronic oedema is a common problem in the community with at least 100000 patients suffering in the UK alone, a problem poorly recognized by health professionals. Lymphoedema arising for reasons other than cancer treatment is much more prevalent than generally perceived, yet resources for treatment are mainly cancer-based, leading to inequalities of care.</EA>
<CC>002B12B06</CC>
<FD>Lymphoedème; Homme; Royaume Uni; Chronique; Evaluation; Soin; Qualité vie; Emploi; Sexe; Age; Santé publique; Epidémiologie; Traitement; Enquête; Questionnaire; Service santé; Personnel sanitaire; Utilisateur; Morbidité</FD>
<FG>Europe; Appareil circulatoire pathologie; Lymphatique pathologie</FG>
<ED>Lymphedema; Human; United Kingdom; Chronic; Evaluation; Care; Quality of life; Employment; Sex; Age; Public health; Epidemiology; Treatment; Survey; Questionnaire; Health service; Health staff; User; Morbidity</ED>
<EG>Europe; Cardiovascular disease; Lymphatic vessel disease</EG>
<SD>Linfedema; Hombre; Reino Unido; Crónico; Evaluación; Cuidado; Calidad vida; Empleo; Sexo; Edad; Salud pública; Epidemiología; Tratamiento; Encuesta; Cuestionario; Servicio sanidad; Personal sanitario; Usuario; Morbilidad</SD>
<LO>INIST-5050.354000114843840040</LO>
<ID>04-0089879</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000655 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000655 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:04-0089879 |texte= Lymphoedema: an underestimated health problem }}
This area was generated with Dilib version V0.6.31. |